
Senior Partnerships Manager @novonordiskfond | Board Member | Former PhD and Post-Doc @CIHR_IRSC @PHRIresearch @McMasterU | 🇩🇰/🇨🇦
Copenhagen, Denmark
Joined September 2010
- Tweets3K
- Following682
- Followers1.5K
- Likes3.9K
Robert W. Morton (Rob) retweeted
11/
This study reinforces a growing conclusion:
Resistance training adaptations are largely governed by endogenous biology, not gym dogma.
If your program works for you, stick with it.
If it doesn’t, changing load alone probably isn’t the answer.
Full paper here 👇
physoc.onlinelibrary.wiley.c…
Robert W. Morton (Rob) retweeted
We show (again) that: Resistance training load does not determine resistance training‐induced hypertrophy across upper and lower limbs in healthy young males physoc.onlinelibrary.wiley.c…
We’re teaming up with @gatesfoundation and @wellcometrust ! A new collaboration marks a significant step towards combatting anti-microbial resistance. More updates to come 🚀! #Collaboration #Partnerships #Innovation #Research
Today, the Novo Nordisk Foundation, Gates Foundation and Wellcome launched a USD 50 million investment that will focus on combatting antimicrobial resistance (AMR).
Read more about the Gram-Negative Antibiotic Discovery Innovator (Gr-ADI) in the press release: novonordiskfonden.dk/en/news…
@gatesfoundation @wellcometrust #AMR #AntimicrobialResistance
A quick and simple description of some unknowns and next steps for GLP-1RA research. An exciting time with important work to be done!
#Research #Innovation #Healthcare
Seven unanswered questions about blockbuster weight-loss drugs | Nature Medicine nature.com/articles/s41591-0…
Robert W. Morton (Rob) retweeted
Absolutely thrilled to share our work recently published in NAR molecular medicine on identifying a non-coding RNA (ncRNA) signature associated with skeletal muscle remodelling. Below is a thread of some (but not all 😉) interesting findings academic.oup.com/narmolmed/a…
Robert W. Morton (Rob) retweeted
Influenza Infection and Acute Myocardial Infarction evidence.nejm.org/doi/full/1…
The role of mitochondrial genes in ischemia-reperfusion injury: A syst... sciencedirect.com/science/ar…
Kudos to Jennifer and @PHRIresearch team with top leadership from @chongm88 !!
Robert W. Morton (Rob) retweeted
Extremely grateful for this amazing honor! 🙏🏻 Grateful for all the amazing colleagues I have had the opportunity to work alongside over the years! See you in Madrid!
Congratulations to Juleen Zierath who is the recipient of the EASD-Novo Nordisk Foundation Diabetes Prize for Excellence 2024! 👏
@JuleenRZierath receives the award at #EASD2024 in Madrid to recognise her outstanding achievements in #diabetes #research.
@novonordiskfond
Sun is shining, new opportunities at work, and surrounded by good colleagues and friends here in Copenhagen. Lots to be grateful for over the past two years living in Denmark!
Robert W. Morton (Rob) retweeted
Solutions start with scientific discovery.
And if we work together, we can improve health faster.
That’s why I’m excited for @wellcometrust to partner with @novonordiskfond and @gatesfoundation on this $300 million initiative. wellcome.org/news/novo-nordi…
Robert W. Morton (Rob) retweeted
Three health foundations tackle biggest disease threats in $300mn deal @wellcometrust @novonordiskfond @gatesfoundation ft.com/content/6218d8bc-901b… via @ft
Robert W. Morton (Rob) retweeted
Collaboration will accelerate the discovery of solutions to urgent health challenges.
Here’s why we’re excited to be partnering with @novonordiskfond and @gatesfoundation on a new initiative to support critical research and development.
🧵[1/6]
Robert W. Morton (Rob) retweeted
Our new 3-year, $300 million partnership with @NovoNordiskFond & @WellcomeTrust will support researchers around the world working to develop next-generation solutions to the world’s more pressing global health challenges. Read more: gates.ly/4bpBZdJ
Robert W. Morton (Rob) retweeted
Today, we announced a three-year partnership with @wellcometrust and the @gatesfoundation to support critical scientific research and development for global health.
At the Novo Nordisk Foundation Global Science Summit in Denmark, our CEO Mads Krogsgaard Thomsen was joined by John-Arne Røttingen, Bill Gates, Dr. Catherine Kyobutungi and Dr Ismahane Elouafi to discuss the initiative and its potential to accelerate global health equity and impact.
An exciting partnership announcement from @novonordiskfond @gatesfoundation and @wellcometrust ! USD $300 million to tackle climate/sustainability, infectious disease, and their interactions.
#globalhealth #partnership #funding
Joint partnership will support science to tackle a series of global health challenges and build healthier futures, especially for the world’s most vulnerable populations.
novonordiskfonden.dk/en/news…
Come join the 2025 INTERACT Symposium to hear about @novonordiskfond ‘s latest Challenge Grant (up to EUR ~8 mil)! We need to better understand and find solutions for the increasing dual-burden of #infectious and #cardiometabolic diseases. linkedin.com/events/the2025i…
Exciting new grant opportunity to tackle major health and societal challenges with Danish partners
The Novo Nordisk Foundation is excited to announce the four themes of its Challenge Programme 2025. The Programme addresses some of the major challenges facing society and the planet at large. It has a total budget of DKK 480 million (€64.3 million) and is now open for applications. Follow the link and watch the Foundation’s leadership team explain the relevance of each new research theme in short films.
#challengeprogramme
novonordiskfonden.dk/en/news…














